{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:57:14Z","timestamp":1759683434732},"reference-count":19,"publisher":"SLACK, Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychosoc Nurs Ment Health Serv"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:p>\n            Opioid receptors are widely distributed throughout the nervous system. In addition to their central role in brain pathways mediating pain, endogenous opioid peptides function as neuromodulators and opioid systems are involved in many physiological functions. Opioid receptor drugs, including methadone (Dolophine\n            <jats:sup>\u00ae<\/jats:sup>\n            ), buprenorphine (Buprenex\n            <jats:sup>\u00ae<\/jats:sup>\n            , Subutex\n            <jats:sup>\u00ae<\/jats:sup>\n            ), naltrexone (Revia\n            <jats:sup>\u00ae<\/jats:sup>\n            ), naloxone (Narcan\n            <jats:sup>\u00ae<\/jats:sup>\n            ), and buprenorphine\/naloxone (Suboxone\n            <jats:sup>\u00ae<\/jats:sup>\n            ), are the focus of this article. This class of drugs is likely to be further developed for the treatment of addictions and mood disorders.\n          <\/jats:p>","DOI":"10.3928\/02793695-20100408-01","type":"journal-article","created":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T17:12:25Z","timestamp":1272042745000},"page":"11-14","source":"Crossref","is-referenced-by-count":2,"title":["The Diverse Clinical Uses of Opioid Receptor Drugs"],"prefix":"10.3928","volume":"48","author":[{"given":"Robert H.","family":"Howland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024933904144"},{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161209788168100"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00207250"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024977719165"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199502000-00008"},{"key":"e_1_3_1_7_1","first-page":"253","article-title":"Neuroendocrine and behavioral effects of naloxone in Tourette syndrome","volume":"58","author":"Chappell P.B.","year":"1992","unstructured":"Chappell, P.B., Leckman, J.F., Riddle, M.A., Anderson, G.M., Listwack, S.J., Ort, S.I.. (1992). Neuroendocrine and behavioral effects of naloxone in Tourette syndrome. Advances in Neurology, 58, 253\u2013262.","journal-title":"Advances in Neurology"},{"issue":"3","key":"e_1_3_1_8_1","first-page":"332","article-title":"Clinical trial of naltrexone in premenstrual syndrome","volume":"72","author":"Chuong C.J.","year":"1988","unstructured":"Chuong, C.J., Coulam, C.B., Bergstralh, E.J., O'Fallon, W.M., & Steinmetz, G.I. (1988). Clinical trial of naltrexone in premenstrual syndrome. Obstetrics and Gynecology, 72(3 Part 1), 332\u2013336.","journal-title":"Obstetrics and Gynecology"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.137.12.1583"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1982.tb39483.x"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt197011141"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1982.tb39488.x"},{"key":"e_1_3_1_13_1","first-page":"77","article-title":"Bulimia as a form of self-addiction: Treatment with naltrexone hydrochloride (Trexan\u00ae)\u2014A pilot study","volume":"27","author":"Huseman C.A.","year":"1990","unstructured":"Huseman, C.A., Pearson, P.H., Madison, J., & Leuschen, M.P. (1990). Bulimia as a form of self-addiction: Treatment with naltrexone hydrochloride (Trexan\u00ae)\u2014A pilot study. Clinical Trials Journal, 27, 77\u201383.","journal-title":"Clinical Trials Journal"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91822-2"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(90)90035-O"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300105"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(88)90083-2"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198904000-00004"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb06740.x"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(89)90197-2"}],"container-title":["Journal of Psychosocial Nursing and Mental Health Services"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/02793695-20100408-01","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T09:44:12Z","timestamp":1683107052000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/02793695-20100408-01"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.3928\/02793695-20100408-01"],"URL":"https:\/\/doi.org\/10.3928\/02793695-20100408-01","relation":{},"ISSN":["0279-3695","1938-2413"],"issn-type":[{"value":"0279-3695","type":"print"},{"value":"1938-2413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}